腸閉塞の世界市場レポート 2025年

腸閉塞の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.1％で55億2,000万米ドルに成長します。予測期間の成長は、継続的な医学教育イニシアティブ、小児ワクチン接種プログラム、小児ヘルスケアにおける世界の取り組み、術後ケアへの注力、小児消化管調査需要の高まり、遠隔医療、遠隔医療アクセスなどに起因すると考えられます。予測期間の主な動向としては、画像診断の進歩、低侵襲治療アプローチ、小児に特化した介入の開発、病因とリスク要因の研究、世界の疫学研究、ワクチン接種プログラムの実施、診断と相談のための遠隔医療などが挙げられます。

予想される腸疾患の発生率の上昇が、今後の腸閉塞市場の成長を牽引するものと思われます。腸疾患には、消化器系で重要な役割を果たす腸の正常な機能に影響を及ぼすさまざまな病状が含まれます。炎症性腸疾患や消化管がんなどの腸疾患の増加が、早期診断、治療選択肢の改善、腸閉塞患者のサポート強化につながり、最終的には健康状態の改善に寄与します。例えば、2023年1月の米国がん協会（ACS）のデータでは、米国における消化器がんの罹患数が3.18％増加し、2021年の338,090例に対して348,840例に達することが明らかになりました。したがって、腸疾患の罹患率の上昇が腸閉塞市場の成長を促進すると予想されます。

腸閉塞市場の成長は、ヘルスケア支出の増加によって促進されています。この用語は、特定の地域、国、または組織内のヘルスケア部門に割り当てられた総財源を包含しています。ヘルスケア支出の増加は、腸閉塞のような病態に関連した医療介入、診断処置、潜在的な外科治療の必要性によって引き起こされることが多く、ひいては医療費全体に影響を及ぼします。例えば、2023年11月、カナダを拠点とするCanadian Institute for Health Informationは、2023年のカナダの総医療費は3,440億米ドルに達し、一人当たり平均8,740ドルになると予測しました。これは、2022年の医療費の伸びがわずか1.5％であった前年と比較すると2.8％の増加であり、ヘルスケア投資の大幅な回復を示しています。このように、医療支出の増加が腸閉塞市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腸閉塞PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の腸閉塞市場：成長率分析
• 世界の腸閉塞市場の実績：規模と成長, 2019-2024
• 世界の腸閉塞市場の予測：規模と成長, 2024-2029, 2034F
• 世界腸閉塞総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腸閉塞市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 特発性腸閉塞
• セカンダリ腸閉塞
• 世界の腸閉塞市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 浣腸の軽減
• 手術
• その他の治療
• 世界の腸閉塞市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• バリウム注腸
• 超音波
• X線
• コンピュータ断層撮影（CT）
• 世界の腸閉塞市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界の腸閉塞市場、特発性腸重積症の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児特発性腸閉塞
• 成人特発性腸閉塞
• 世界の腸閉塞市場二次腸重積症のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍性腸閉塞
• 感染性腸閉塞
• 炎症性の腸閉塞
• 術後腸閉塞

第7章 地域別・国別分析

• 世界の腸閉塞市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腸閉塞市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腸閉塞市場：競合情勢
• 腸閉塞市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Sanofi S.A.
• GlaxoSmithKline plc
• Stryker Corporation
• Boston Scientific Corporation
• Biogen Inc.
• Olympus Corporation
• GE HealthCare Technologies Inc.
• Steris Plc
• Cook Medical LLC
• Shimadzu Corporation
• Carestream Health
• CONMED Corporation
• Janssen Pharmaceuticals Inc.
• EndoChoice Holdings Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腸閉塞市場2029：新たな機会を提供する国
• 腸閉塞市場2029：新たな機会を提供するセグメント
• 腸閉塞市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Intussusception is a medical condition wherein one part of the intestine slides into an adjacent section, causing a blockage in the flow of food, fluids, and gas through the affected portion. This condition manifests with symptoms such as severe abdominal pain, vomiting, and bloody stools. Diagnosis of intussusception typically relies on symptoms, physical examination, and imaging tests.

There are two main types of intussusception are idiopathic intussusception and secondary intussusception. Idiopathic intussusception involves the telescoping or invagination of one part of the intestine into another, resulting in a blockage or obstruction that can often be treated non-surgically through procedures such as pneumatic or hydrostatic reduction. Treatment methods include enema reduction, surgery, and others, with diagnostic approaches such as barium enema, ultrasound, and X-ray. These services are generally provided by hospitals, clinics, and other medical facilities.

The intussusception market research report is one of a series of new reports from The Business Research Company that provides intussusception market statistics, including intussusception industry global market size, regional shares, competitors with an intussusception market share, detailed intussusception market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. This intussusception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intussusception market size has grown strongly in recent years. It will grow from $4.45 billion in 2024 to $4.69 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to improved diagnostic capabilities, increased awareness and education, global healthcare infrastructure growth, research and development investments, collaboration among healthcare entities.

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.52 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to continued medical education initiatives, pediatric vaccination programs, global efforts in pediatric healthcare, focus on postoperative care, rising demand for pediatric gastrointestinal research, telemedicine and remote healthcare access. Major trends in the forecast period include advancements in diagnostic imaging, minimally invasive treatment approaches, development of pediatric-specific interventions, research on etiology and risk factors, global epidemiological studies, implementation of vaccination programs, telemedicine for diagnosis and consultation.

The anticipated rise in the incidence of intestinal disorders is poised to drive the growth of the intussusception market in the future. Intestinal disorders encompass various medical conditions affecting the normal functioning of the intestines, which play a crucial role in the digestive system. The increasing occurrence of intestinal disorders, such as inflammatory bowel disease and gastrointestinal cancers, can lead to earlier diagnoses, improved treatment options, and enhanced support for patients with intussusception, ultimately contributing to better health outcomes. For instance, data from the American Cancer Society (ACS) in January 2023 revealed a 3.18% increase in gastrointestinal cancers in the United States, reaching 348,840 cases compared to 338,090 in 2021. Therefore, the rising incidence of intestinal disorders is expected to drive the growth of the intussusception market.

The growth of the intussusception market is being fueled by rising healthcare spending. This term encompasses the total financial resources allocated to the healthcare sector within a particular region, country, or organization. Increased healthcare spending is often driven by the need for medical interventions, diagnostic procedures, and potential surgical treatments associated with conditions like intussusception, which in turn affects overall healthcare expenditure. For example, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, averaging $8,740 per person. This represents a 2.8% increase compared to the previous year, which experienced a mere 1.5% growth in health spending in 2022, indicating a significant recovery in healthcare investment. Thus, the rise in healthcare spending is contributing to the growth of the intussusception market.

Major companies in the intestinal pseudo-obstruction treatment market are actively involved in developing innovative drug therapies, such as NHE3 inhibitor treatment therapy, to provide reliable services to customers. NHE3 inhibitor treatment therapy involves the inhibition of the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For example, in April 2022, Ardelyx Inc., a US-based biopharmaceutical company, introduced IBSRELA, an NHE3 inhibitor treatment designed for irritable bowel syndrome with constipation (IBS-C) in adults. This therapy has the potential to improve gastrointestinal motility by inhibiting or blocking the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The approval of IBSRELA was based on two Phase 3 trials involving over 1,200 IBS-C patients. The treatment significantly improved abdominal pain and bowel movements, meeting the primary endpoint. Notably, improvements were observed as early as Week 1 and sustained for 26 weeks in the long-term trial.

In March 2022, Pfizer Inc., a prominent US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. This acquisition is part of Pfizer's strategic efforts to bolster its portfolio of therapeutic candidates at various stages of development within the field of gastroenterology. Arena Pharmaceuticals, Inc., a US-based clinical-stage company, is actively involved in developing treatments for intestinal diseases, including intussusception (bowel obstruction). The acquisition aligns with Pfizer's commitment to advancing research and development in gastrointestinal therapeutics.

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intussusception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intussusception Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intussusception market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intussusception ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intussusception market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Idiopathic Intussusception; Secondary Intussusception
• 2) By Treatment: Enema Reduction; Surgery; Other Treatment
• 3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)
• 4) By End-User: Hospitals; Clinics; Other End-User
• Subsegments:
• 1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception
• 2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Bayer AG; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intussusception Market Characteristics

3. Intussusception Market Trends And Strategies

4. Intussusception Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Intussusception Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intussusception PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intussusception Market Growth Rate Analysis
• 5.4. Global Intussusception Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intussusception Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intussusception Total Addressable Market (TAM)

6. Intussusception Market Segmentation

• 6.1. Global Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Intussusception
• Secondary Intussusception
• 6.2. Global Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enema Reduction
• Surgery
• Other Treatment
• 6.3. Global Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Barium Enema
• Ultrasound
• X-Ray
• Computerized Tomography (CT)
• 6.4. Global Intussusception Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-User
• 6.5. Global Intussusception Market, Sub-Segmentation Of Idiopathic Intussusception, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Childhood Idiopathic Intussusception
• Adult Idiopathic Intussusception
• 6.6. Global Intussusception Market, Sub-Segmentation Of Secondary Intussusception, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neoplastic Intussusception
• Infectious Intussusception
• Inflammatory Intussusception
• Post-Surgical Intussusception

7. Intussusception Market Regional And Country Analysis

• 7.1. Global Intussusception Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intussusception Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intussusception Market

• 8.1. Asia-Pacific Intussusception Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intussusception Market

• 9.1. China Intussusception Market Overview
• 9.2. China Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intussusception Market

• 10.1. India Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intussusception Market

• 11.1. Japan Intussusception Market Overview
• 11.2. Japan Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intussusception Market

• 12.1. Australia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intussusception Market

• 13.1. Indonesia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intussusception Market

• 14.1. South Korea Intussusception Market Overview
• 14.2. South Korea Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intussusception Market

• 15.1. Western Europe Intussusception Market Overview
• 15.2. Western Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intussusception Market

• 16.1. UK Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intussusception Market

• 17.1. Germany Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intussusception Market

• 18.1. France Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intussusception Market

• 19.1. Italy Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intussusception Market

• 20.1. Spain Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intussusception Market

• 21.1. Eastern Europe Intussusception Market Overview
• 21.2. Eastern Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intussusception Market

• 22.1. Russia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intussusception Market

• 23.1. North America Intussusception Market Overview
• 23.2. North America Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intussusception Market

• 24.1. USA Intussusception Market Overview
• 24.2. USA Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intussusception Market

• 25.1. Canada Intussusception Market Overview
• 25.2. Canada Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intussusception Market

• 26.1. South America Intussusception Market Overview
• 26.2. South America Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intussusception Market

• 27.1. Brazil Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intussusception Market

• 28.1. Middle East Intussusception Market Overview
• 28.2. Middle East Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intussusception Market

• 29.1. Africa Intussusception Market Overview
• 29.2. Africa Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intussusception Market Competitive Landscape And Company Profiles

• 30.1. Intussusception Market Competitive Landscape
• 30.2. Intussusception Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Intussusception Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Sanofi S.A.
• 31.3. GlaxoSmithKline plc
• 31.4. Stryker Corporation
• 31.5. Boston Scientific Corporation
• 31.6. Biogen Inc.
• 31.7. Olympus Corporation
• 31.8. GE HealthCare Technologies Inc.
• 31.9. Steris Plc
• 31.10. Cook Medical LLC
• 31.11. Shimadzu Corporation
• 31.12. Carestream Health
• 31.13. CONMED Corporation
• 31.14. Janssen Pharmaceuticals Inc.
• 31.15. EndoChoice Holdings Inc.

32. Global Intussusception Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intussusception Market

34. Recent Developments In The Intussusception Market

35. Intussusception Market High Potential Countries, Segments and Strategies

• 35.1 Intussusception Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intussusception Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intussusception Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer